Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Mapping Pharmacogenomic Determinants of Adverse Drug Reactions in Hypertension: A Systematic Review. Local targets link to admitted publications; unresolved targets remain external evidence.
Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension
10.1097/hjh.0000000000003563 · 2023 · External reference
Unresolved reference
External reference
Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19·1 million participants
10.1016/s0140-6736(16)31919-5 · 2017 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1186/s12916-025-03918-1
10.1186/s12916-025-03918-1 · External reference
Unresolved reference
External reference
Determinants of the high admission blood pressure in mild-to-moderate acute intracerebral hemorrhage
10.1097/hjh.0000000000002056 · 2019 · External reference
10.3389/fphar.2022.848804
10.3389/fphar.2022.848804 · External reference
Antihypertensive Medications
10.1097/00007611-198405000-00020 · 2023 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Thiazide and loop diuretics
10.1111/j.1751-7176.2011.00512.x · 2011 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Factors affecting the development of adverse drug reactions (Review article)
10.1016/j.jsps.2013.02.003 · 2014 · External reference
Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients
10.1161/jaha.122.026582 · 2022 · External reference
Association between medication adherence and blood pressure control and factors associated with antihypertensive medication adherence in the Melaka Tengah District: A cross-sectional survey
10.51866/oa.651 · 2024 · External reference
Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: A cross-sectional study
10.1007/s11096-024-01832-9 · 2025 · External reference
Adverse effects and non-adherence to antihypertensive medications in University of Gondar Comprehensive Specialized Hospital
10.1186/s40885-018-0104-6 · 2019 · External reference
10.3390/pharmaceutics15020404
10.3390/pharmaceutics15020404 · External reference
Pharmacogenomics: Precision Medicine and Drug Response
10.1016/j.mayocp.2017.09.001 · 2017 · External reference
Evaluating the promise of inclusion of African ancestry populations in genomics
10.1038/s41525-019-0111-x · 2020 · External reference
Pharmacogenomics of Hypertension in Africa: Paving the Way for a Pharmacogenetic-Based Approach for the Treatment of Hypertension in Africans
10.1155/2023/9919677 · 2023 · External reference
Impact of limited population diversity of genome-wide association studies
10.1097/gim.0b013e3181ca2bbf · 2010 · External reference
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic
10.1161/hypertensionaha.107.104273 · 2008 · External reference
Genome-wide association studies in neurological disorders
10.1016/s1474-4422(08)70241-2 · 2008 · External reference
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing
10.1002/cpt.709 · 2017 · External reference
Pharmacogenomics and Hypertension: Current Insights
2019 · External reference
A qualitative approach to assess the opinion of physicians about the challenges and prospects of pharmacogenomic testing implementation in clinical practice in Greece
10.1186/s40246-024-00648-y · 2024 · External reference
10.3390/jpm9030040
10.3390/jpm9030040 · External reference
A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: A reality for future health care
10.1038/s41397-024-00326-1 · 2024 · External reference
10.3390/ph16111542
10.3390/ph16111542 · External reference
Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18,820 patients
10.1136/bmj.329.7456.15 · 2004 · External reference
Comprehensive effects of lifestyle reform, adherence, and related factors on hypertension control: A review
10.1111/jch.14653 · 2023 · External reference
10.3389/fnut.2025.1632999
10.3389/fnut.2025.1632999 · External reference
Relationships among medication adherence, lifestyle modification, and health-related quality of life in patients with acute myocardial infarction: A cross-sectional study
10.1186/s12955-018-0921-z · 2018 · External reference
PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews
10.1136/bmj.n160 · 2021 · External reference
10.1186/s12888-024-06104-4
10.1186/s12888-024-06104-4 · External reference
Artificial intelligence (AI) in pharmacovigilance: A systematic review on predicting adverse drug reactions (ADR) in hospitalized patients
10.1016/j.sapharm.2025.02.008 · 2025 · External reference
Adverse drug reactions
10.7861/clinmedicine.16-5-481 · 2016 · External reference
Unresolved reference
External reference
Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough
10.1097/fpc.0b013e328341041c · 2011 · External reference
Association of polymorphisms of the renin–angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough
10.1038/sj.jhh.1001486 · 2002 · External reference
Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans
10.1111/j.1365-2710.2009.01028.x · 2009 · External reference
Association of B2 Receptor Polymorphisms and ACE Activity with ACE Inhibitor–Induced Angioedema in Black and Mixed-Race South Africans
10.1111/jch.12104 · 2013 · External reference
Approaches to predicting the efficacy and safety of amlodipine in patients with arterial hypertension of I–II degree based on pharmacogenetic studies
2019 · External reference
Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension
2021 · External reference
10.3389/fphar.2024.1441251
10.3389/fphar.2024.1441251 · External reference
Unresolved reference
External reference
Peripheral edema associated with calcium channel blockers: Incidence and withdrawal rate—A meta-analysis of randomized trials
10.1097/hjh.0b013e3283472643 · 2011 · External reference
The Pharmacogenomics of Anti-Hypertensive Therapy
10.3390/ph3061779 · 2010 · External reference
Unresolved reference
External reference
Hypertension pharmacogenomics: In search of personalized treatment approaches
10.1038/nrneph.2015.176 · 2016 · External reference
Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions
10.4103/jfmpc.jfmpc_831_21 · 2021 · External reference
Bradykinin B2 Receptor Gene Polymorphism Is Associated with Angiotensin-Converting Enzyme Inhibitor–Related Cough
10.1161/01.hyp.36.1.127 · 2000 · External reference
Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor-58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non [ndash] insulin-dependent diabetes mellitus
10.1053/meta.2001.27212 · 2001 · External reference
10.2139/ssrn.4745871
10.2139/ssrn.4745871 · External reference
Unresolved reference
External reference
Hypertension in Low- and Middle-Income Countries
10.1161/circresaha.120.318729 · 2021 · External reference
10.1186/s12889-025-24766-x
10.1186/s12889-025-24766-x · External reference
10.1136/bmj.n71
10.1136/bmj.n71 · External reference
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing
10.1002/cpt.709 · ExternalCitation · doi-reference
Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: A cross-sectional study
10.1007/s11096-024-01832-9 · ExternalCitation · doi-reference
Factors affecting the development of adverse drug reactions (Review article)
10.1016/j.jsps.2013.02.003 · ExternalCitation · doi-reference
Pharmacogenomics: Precision Medicine and Drug Response
10.1016/j.mayocp.2017.09.001 · ExternalCitation · doi-reference
Artificial intelligence (AI) in pharmacovigilance: A systematic review on predicting adverse drug reactions (ADR) in hospitalized patients
10.1016/j.sapharm.2025.02.008 · ExternalCitation · doi-reference
Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19·1 million participants
10.1016/s0140-6736(16)31919-5 · ExternalCitation · doi-reference
Genome-wide association studies in neurological disorders
10.1016/s1474-4422(08)70241-2 · ExternalCitation · doi-reference
Hypertension pharmacogenomics: In search of personalized treatment approaches
10.1038/nrneph.2015.176 · ExternalCitation · doi-reference
A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: A reality for future health care
10.1038/s41397-024-00326-1 · ExternalCitation · doi-reference
Evaluating the promise of inclusion of African ancestry populations in genomics
10.1038/s41525-019-0111-x · ExternalCitation · doi-reference
Association of polymorphisms of the renin–angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough
10.1038/sj.jhh.1001486 · ExternalCitation · doi-reference
Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor-58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non [ndash] insulin-dependent diabetes mellitus
10.1053/meta.2001.27212 · ExternalCitation · doi-reference
Antihypertensive Medications
10.1097/00007611-198405000-00020 · ExternalCitation · doi-reference
Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough
10.1097/fpc.0b013e328341041c · ExternalCitation · doi-reference
Impact of limited population diversity of genome-wide association studies
10.1097/gim.0b013e3181ca2bbf · ExternalCitation · doi-reference
Determinants of the high admission blood pressure in mild-to-moderate acute intracerebral hemorrhage
10.1097/hjh.0000000000002056 · ExternalCitation · doi-reference
Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension
10.1097/hjh.0000000000003563 · ExternalCitation · doi-reference
Peripheral edema associated with calcium channel blockers: Incidence and withdrawal rate—A meta-analysis of randomized trials
10.1097/hjh.0b013e3283472643 · ExternalCitation · doi-reference
Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans
10.1111/j.1365-2710.2009.01028.x · ExternalCitation · doi-reference
Thiazide and loop diuretics
10.1111/j.1751-7176.2011.00512.x · ExternalCitation · doi-reference
Association of B2 Receptor Polymorphisms and ACE Activity with ACE Inhibitor–Induced Angioedema in Black and Mixed-Race South Africans
10.1111/jch.12104 · ExternalCitation · doi-reference
Comprehensive effects of lifestyle reform, adherence, and related factors on hypertension control: A review
10.1111/jch.14653 · ExternalCitation · doi-reference
Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18,820 patients
10.1136/bmj.329.7456.15 · ExternalCitation · doi-reference
PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews
10.1136/bmj.n160 · ExternalCitation · doi-reference
10.1136/bmj.n71
10.1136/bmj.n71 · ExternalCitation · doi-reference
Pharmacogenomics of Hypertension in Africa: Paving the Way for a Pharmacogenetic-Based Approach for the Treatment of Hypertension in Africans
10.1155/2023/9919677 · ExternalCitation · doi-reference
Bradykinin B2 Receptor Gene Polymorphism Is Associated with Angiotensin-Converting Enzyme Inhibitor–Related Cough
10.1161/01.hyp.36.1.127 · ExternalCitation · doi-reference
Hypertension in Low- and Middle-Income Countries
10.1161/circresaha.120.318729 · ExternalCitation · doi-reference
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic
10.1161/hypertensionaha.107.104273 · ExternalCitation · doi-reference
Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients
10.1161/jaha.122.026582 · ExternalCitation · doi-reference
10.1186/s12888-024-06104-4
10.1186/s12888-024-06104-4 · ExternalCitation · doi-reference
10.1186/s12889-025-24766-x
10.1186/s12889-025-24766-x · ExternalCitation · doi-reference
10.1186/s12916-025-03918-1
10.1186/s12916-025-03918-1 · ExternalCitation · doi-reference
Relationships among medication adherence, lifestyle modification, and health-related quality of life in patients with acute myocardial infarction: A cross-sectional study
10.1186/s12955-018-0921-z · ExternalCitation · doi-reference
A qualitative approach to assess the opinion of physicians about the challenges and prospects of pharmacogenomic testing implementation in clinical practice in Greece
10.1186/s40246-024-00648-y · ExternalCitation · doi-reference
Adverse effects and non-adherence to antihypertensive medications in University of Gondar Comprehensive Specialized Hospital
10.1186/s40885-018-0104-6 · ExternalCitation · doi-reference
10.2139/ssrn.4745871
10.2139/ssrn.4745871 · ExternalCitation · doi-reference
10.3389/fnut.2025.1632999
10.3389/fnut.2025.1632999 · ExternalCitation · doi-reference
10.3389/fphar.2022.848804
10.3389/fphar.2022.848804 · ExternalCitation · doi-reference
10.3389/fphar.2024.1441251
10.3389/fphar.2024.1441251 · ExternalCitation · doi-reference
10.3390/jpm9030040
10.3390/jpm9030040 · ExternalCitation · doi-reference
10.3390/ph16111542
10.3390/ph16111542 · ExternalCitation · doi-reference
The Pharmacogenomics of Anti-Hypertensive Therapy
10.3390/ph3061779 · ExternalCitation · doi-reference
10.3390/pharmaceutics15020404
10.3390/pharmaceutics15020404 · ExternalCitation · doi-reference
Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions
10.4103/jfmpc.jfmpc_831_21 · ExternalCitation · doi-reference
Association between medication adherence and blood pressure control and factors associated with antihypertensive medication adherence in the Melaka Tengah District: A cross-sectional survey
10.51866/oa.651 · ExternalCitation · doi-reference
Adverse drug reactions
10.7861/clinmedicine.16-5-481 · ExternalCitation · doi-reference
